Abstract:Background and aims CCL5 is considered to contribute to the biological function of a variety of cancer types, but its specific mechanism is still unclear. This study aimed to reveal the mechanism of CCL5 in the invasion, metastasis, and prognosis of breast cancer. Methods The expression of CCL5 in tumor tissue and serum was measured with a Luminex protein detection kit, and the correlation between CCL5 and clinical parameters was evaluated. Kaplan–Meier analysis was used to analyze the effect of CCL5 on the prognosis of breast cancer patients. Protein interaction network analysis and gene coexpression were used to determine the receptor that has the strongest interaction with CCL5. Enrichment analysis was used to study the possible pathway by which CCL5 affects breast cancer progression. We used immunofluorescence staining and flow cytometry to estimate the fraction of immunity-related components in the tumor microenvironment. Results The expression level of CCL5 in breast cancer patients was positively correlated with the degree of axillary lymph node metastasis; CCL5 in tumor tissue was correlated with estrogen receptor status ( P = 0.034), progesterone receptor ( P = 0.009), nuclear grade ( P = 0.013), clinical stage ( P < 0.001) and molecular subtype ( P = 0.024) in breast cancer patients. Breast cancer patients with high CCL5 expression had worse disease-free survival ( P = 0.031) and breast cancer-specific survival ( P = 0.043); however, CCL5 had no effect on overall survival ( P = 0.077). CCL5 affected tumor progression through CCR5, and the T-cell-related immune pathway may be the main pathway; the CD4+/CD8+, CCR5+/CD4+ and Treg/CCR5+ cell ratios were significantly increased in the lymph node metastasis group. Conclusion CCL5 affects the Treg/CD4+CCR5+ cell ratio in breast cancer patients through CCR5, thus affecting breast cancer metastasis and prognosis.

Expression of CCR5 in Breast Cancer Stem Cells and Its Significance

Effects of Breast Cancer Stromal Cells on Expression of Wnt1,Notch1 and Β-Catenin and Migration of MCF-7 Cells

CC Chemokine-5 Induces the Chemotaxis and Invasion of Breast Cancer Cells

Expression and significance of CCL5 and receptors on breast cancer

CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion

Expression of CCL5 and it's clinical significance in breast cancer

Intratumoral Expression Of Ccr3 In Breast Cancer Is Associated With Improved Relapse-Free Survival In Luminal-Like Disease

Quantitative Analyses of CD133 Expression Facilitate Researches on Tumor Stem Cells.

Supplemental Figure 1-11 from CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion

CCL5 mediates breast cancer metastasis and prognosis through CCR5/Treg cells

Relationship Between Expression of CCR5 and C-Erbb-2 in Breast Cancer and Lymph Nodes Metastasis

High Expression of CCR5 in Melanoma Enhances Epithelial–mesenchymal Transition and Metastasis Via TGFβ1

Expression of chemokine receptor CCR7 in human colon cancer tissues and its correlation with clinicopathological characteristics

The Expression and Significance of Multi-Drug Resistance Genes in Breast Cancer Stem Cells

[Expression of Chemokine Receptor CXCR6 and Its Significance in Breast Cancer Cell Lines].

CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer

Effect of CCL5 on Cell Proliferation and the Proportion of CD44~+/CD2~4-subpopulation of Breast Cancer Cell Line MCF-7

Stromal CCL5 Promotes Breast Cancer Progression by Interacting with CCR3 in Tumor Cells

Investigation on the Correlation Between Circulating Tumor Cells and Cancer Stem Cells in Patients with Breast Cancer

Expression and Significance of Chemokine Receptor CXC Chemokine Receptor-5 and Its Ligand CXCL13 in Colon Cancer

Correlation Between CCL5 Expression and the Ability of Invasion in Four Human Breast Tumor Cell Lines